Advancing preparedness for clinical research during infectious disease epidemics

ERJ Open Research

Volumn 5, Issue 2, 2019, Pages

  Gobat, Nina ^a   Amuasi, John ^b   Yazdanpanah, Yazdan ^c   Sigfid, Louise ^d   Davies, Hugh ^e   Byrne, John Paul ^f   Carson, Gail ^d   Butler, Christopher ^a   Nichol, Alistair ^f   Goossens, Herman ^g  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b KUMASI CENTRE FOR COLLABORATIVE RESEARCH IN TROPICAL MEDICINE   (Ghana)

^c BICHAT HOSPITAL   (France)

^d UNIVERSITY OF OXFORD   (United Kingdom)

^e Oxford NHS Research Ethics Committee   (United Kingdom)

^f UNIVERSITY COLLEGE DUBLIN   (Ireland)

^g UNIVERSITY OF ANTWERP   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

OSELTAMIVIR;

ANTICIPATION; CLIMATE CHANGE; CLINICAL DECISION MAKING; CLINICAL RESEARCH; COMMUNITY ACQUIRED PNEUMONIA; EDITORIAL; EPIDEMIC; GLOBAL HEALTH; HEALTH CARE COST; HEALTH CARE DELIVERY; HUMAN; INFECTION; INTERSECTORAL COLLABORATION; MEDICAL COUNTERMEASURE; MEDICAL RESEARCH; POLITICS; POPULATION GROWTH; PROFESSIONAL PRACTICE; PUBLIC HEALTH SYSTEMS RESEARCH; RESPIRATORY TRACT INFECTION; SEPSIS; SOCIOECONOMICS; SPANISH INFLUENZA; STAKEHOLDER ENGAGEMENT;

EID: 85076686133     PISSN: None     EISSN: 23120541     Source Type: Journal    
DOI: 10.1183/23120541.00227-2018     Document Type: Editorial

References (21)

1. Taubenberger JK, Morens DM. 1918 influenza: the mother of all pandemics. Emerging Infect Dis 2006; 12: 15–22.
2. Smith KF, Goldberg M, Rosenthal S, et al. Global rise in human infectious disease outbreaks. J R Soc Interface 2014; 11: 20140950.
3. Leigh J, Moon S, Garcia E, et al. Is global capacity to manage outbreaks improving? An analysis. Geneva, Graduate Institute of International and Development Studies, 2018.
4. Rojek AM, Horby PW. Modernising epidemic science: enabling patient-centred research during epidemics. BMC Med 2016; 14: 212.
5. Commission on a Global Health Risk Framework for the Future. The neglected dimension of global security: a framework to counter infectious disease crises. 2016. http://nam.edu/GHRFreport
6. Lurie N, Manolio T, Patterson AP, et al. Research as a part of public health emergency response. N Engl J Med 2013; 368: 1251–1255.
7. Mehand MS, Al-Shorbaji F, Millett P, et al. The WHO R&D Blueprint: 2018 review of emerging infectious diseases requiring urgent research and development efforts. Antiviral Res 2018; 159: 63–67.
8. Matthiessen L, Colli W, Delfraissy J-F, et al. Coordinating funding in public health emergencies. Lancet 2016; 387: 2197–2198.
9. Gobat N, Sigfrid L, Maskell K, et al. Reaching out: a meeting to advance clinical research preparedness for infectious disease outbreaks. 2018. www.prepare-europe.eu/Portals/0/Documents/Publications/Reaching%20Out%20Report_ PREPARE%20GloPID-R_Final_2018%2011%2019.pdf?timestamp=1542643918696×tamp=1542643918696
10. Lim WS, Brittain C, Duley L, et al. Blinded randomised controlled trial of low-dose Adjuvant Steroids in Adults admitted to hospital with Pandemic influenza (ASAP): a trial “in hibernation”, ready for rapid activation. Health Technol Assess 2015; 19: 1–78.
11. Gobat NH, Gal M, Butler CC, et al. Talking to the people that really matter about their participation in pandemic clinical research: a qualitative study in four European countries. Health Expect 2018; 21: 387–395.
12. Van Kerkhove MD, Reveiz L, Souza JP, et al. Harmonisation of Zika virus research protocols to address key public health concerns. Lancet Glob Health 2016; 4: e911–e912.
13. Platform for European Preparedness Against (Re-) emerging Epidemics. 3. Practice A: observational study – workpackage 3. www.prepare-europe.eu/About-us/Workpackages/Workpackage-3
14. Berry SM, Connor JT, Lewis RJ. The platform trial: an efficient strategy for evaluating multiple treatments. JAMA 2015; 313: 1619–1620.
15. 4 E: why design a platform, response-adaptive, open, randomised controlled trial of antivirals for influenza-like illness? ERJ Open Res 2018; 4: 00046–02018.
16. Bongard E, van der Velden AW, Cook J, et al. Antivirals for influenza-Like Illness? A randomised Controlled trial of Clinical and Cost effectiveness in primary CarE (ALIC4E): the ALIC4E protocol. BMJ Open 2018; 8: e021032.
17. Platform for European Preparedness Against (Re-) emerging Epidemics. 5. Practice C: Randomized, embedded, multifactorial, adaptive platform trial severe CAP – workpackage 5. www.prepare-europe.eu/About-us/ Workpackages/Workpackage-5
18. Byrne J-P, Rahmani M, Davies H, et al. Pandemic research preparedness survey of national competent authorities and research ethics committees across Europe. Antwerp, PREPARE WP1, 2018.
19. ALERRT. “Ethics preparedness”: Facilitating Ethics Review During Outbreaks. Recommendations arising from a joint ALERRT & WHO workshop. 2018. www.alerrt.global/sites/www.alerrt.org/files/2018-06/alerrt_workshop_ recommendations_final_30may18_0.pdf
20. TDR Research Fairness Initiative report. Geneva, World Health Organization, 2018.
21. Webb SA, Nichol AD. Bending the pandemic curve: improving decision-making with clinical research. Crit Care Med 2018; 46: 442–446.